These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 12894712)

  • 21. Gemcitabine and S-1 combination chemotherapy versus gemcitabine alone for locally advanced and metastatic pancreatic cancer: a meta-analysis of randomized controlled trials in Asia.
    Li Y; Sun J; Jiang Z; Zhang L; Liu G
    J Chemother; 2015 Aug; 27(4):227-34. PubMed ID: 25790948
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adjuvant chemotherapy with gemcitabine and long-term outcomes among patients with resected pancreatic cancer: the CONKO-001 randomized trial.
    Oettle H; Neuhaus P; Hochhaus A; Hartmann JT; Gellert K; Ridwelski K; Niedergethmann M; Zülke C; Fahlke J; Arning MB; Sinn M; Hinke A; Riess H
    JAMA; 2013 Oct; 310(14):1473-81. PubMed ID: 24104372
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Marimastat as first-line therapy for patients with unresectable pancreatic cancer: a randomized trial.
    Bramhall SR; Rosemurgy A; Brown PD; Bowry C; Buckels JA;
    J Clin Oncol; 2001 Aug; 19(15):3447-55. PubMed ID: 11481349
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gemcitabine chemotherapy versus 5-fluorouracil-based concurrent chemoradiotherapy in locally advanced unresectable pancreatic cancer.
    Park JK; Ryu JK; Lee JK; Yoon WJ; Lee SH; Kim YT; Yoon YB
    Pancreas; 2006 Nov; 33(4):397-402. PubMed ID: 17079946
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Gemcitabine in elderly patients with unresectable pancreas cancer].
    Hanada K; Hino F; Amano H; Ooe H; Hirota Y; Sasao S; Obayashi M; Kajiyama G
    Gan To Kagaku Ryoho; 2002 Dec; 29(13):2521-5. PubMed ID: 12506475
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Advanced breast cancer: a phase II trial with gemcitabine.
    Carmichael J; Possinger K; Phillip P; Beykirch M; Kerr H; Walling J; Harris AL
    J Clin Oncol; 1995 Nov; 13(11):2731-6. PubMed ID: 7595731
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A phase I trial of weekly gemcitabine administered as a prolonged infusion in patients with pancreatic cancer and other solid tumors.
    Brand R; Capadano M; Tempero M
    Invest New Drugs; 1997; 15(4):331-41. PubMed ID: 9547676
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activity of gemcitabine in non-small-cell lung cancer: results of the Japan gemcitabine group (A) phase II study.
    Takada M; Negoro S; Kudo S; Furuse K; Nishikawa H; Takada Y; Kamei T; Niitani H; Fukuoka M
    Cancer Chemother Pharmacol; 1998; 41(3):217-22. PubMed ID: 9443638
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase II study of gemcitabine in patients with advanced pancreatic cancer.
    Carmichael J; Fink U; Russell RC; Spittle MF; Harris AL; Spiessi G; Blatter J
    Br J Cancer; 1996 Jan; 73(1):101-5. PubMed ID: 8554969
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TAS-118 (S-1 plus leucovorin) versus S-1 in patients with gemcitabine-refractory advanced pancreatic cancer: a randomised, open-label, phase 3 study (GRAPE trial).
    Ioka T; Ueno M; Ueno H; Park JO; Chang HM; Sasahira N; Kanai M; Chung IJ; Ikeda M; Nakamori S; Mizuno N; Omuro Y; Yamaguchi T; Hara H; Sugimori K; Furuse J; Maguchi H; Furukawa M; Fukuzawa K; Kim JS; Yukisawa S; Takeuchi M; Okusaka T; Boku N; Hyodo I
    Eur J Cancer; 2019 Jan; 106():78-88. PubMed ID: 30471651
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decreased myelotoxicity of gemcitabine and cisplatin in advanced non-small cell lung cancer (NSCLC) with cisplatin infusion on day 15.
    Cortesi E; Ramponi S; Corona M; Moscetti L; Grifalchi F; Oliva A; Lembo A; Gasperoni S; Padovani A
    Lung Cancer; 2001; 31(2-3):271-6. PubMed ID: 11165407
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A multicenter phase II study of gemcitabine and S-1 combination chemotherapy in patients with unresectable pancreatic cancer.
    Oh DY; Cha Y; Choi IS; Yoon SY; Choi IK; Kim JH; Oh SC; Kim CD; Kim JS; Bang YJ; Kim YH
    Cancer Chemother Pharmacol; 2010 Feb; 65(3):527-36. PubMed ID: 19578850
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phase II trial of gemcitabine as first line chemotherapy in patients with metastatic or unresectable soft tissue sarcoma.
    Von Burton G; Rankin C; Zalupski MM; Mills GM; Borden EC; Karen A
    Am J Clin Oncol; 2006 Feb; 29(1):59-61. PubMed ID: 16462504
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gemcitabine therapy in patients with advanced pancreatic cancer.
    Min YJ; Joo KR; Park NH; Yun TK; Nah YW; Nam CW; Park JH
    Korean J Intern Med; 2002 Dec; 17(4):259-62. PubMed ID: 12647642
    [TBL] [Abstract][Full Text] [Related]  

  • 35. S-1 monotherapy as second-line treatment for advanced pancreatic cancer after gemcitabine failure.
    Todaka A; Fukutomi A; Boku N; Onozawa Y; Hironaka S; Yasui H; Yamazaki K; Taku K; Machida N; Sakamoto T; Tomita H
    Jpn J Clin Oncol; 2010 Jun; 40(6):567-72. PubMed ID: 20189975
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phase II study of gemcitabine chemotherapy alone for locally advanced pancreatic carcinoma: JCOG0506.
    Ishii H; Furuse J; Boku N; Okusaka T; Ikeda M; Ohkawa S; Fukutomi A; Hamamoto Y; Nakamura K; Fukuda H;
    Jpn J Clin Oncol; 2010 Jun; 40(6):573-9. PubMed ID: 20185458
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Randomized phase III trial of gemcitabine plus cisplatin compared with gemcitabine alone in advanced pancreatic cancer.
    Heinemann V; Quietzsch D; Gieseler F; Gonnermann M; Schönekäs H; Rost A; Neuhaus H; Haag C; Clemens M; Heinrich B; Vehling-Kaiser U; Fuchs M; Fleckenstein D; Gesierich W; Uthgenannt D; Einsele H; Holstege A; Hinke A; Schalhorn A; Wilkowski R
    J Clin Oncol; 2006 Aug; 24(24):3946-52. PubMed ID: 16921047
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Usefulness of gemcitabine in the treatment of advanced pancreatic cancer in terms of its clinical benefits].
    Shiozawa S; Tsuchiya A; Kumazawa K; Ogawa K
    Gan To Kagaku Ryoho; 2003 Apr; 30(4):483-7. PubMed ID: 12722678
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A phase II study of single-agent gemcitabine as a second-line treatment in advanced non-small cell lung cancer.
    Cho KH; Song YB; Choi IS; Cho EH; Choi JW; Ahn YM; Roh YH; Nam SH; Kim BS
    Jpn J Clin Oncol; 2006 Jan; 36(1):50-4. PubMed ID: 16418187
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical impact of radiotherapy for locally advanced pancreatic cancer.
    Sawaki A; Hoki N; Ito S; Matsumoto K; Mizuno N; Hara K; Takagi T; Kobayashi Y; Sawai Y; Kawai H; Tajika M; Nakamura T; Yamao K
    J Gastroenterol; 2009; 44(12):1209-14. PubMed ID: 19705054
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.